Table 4.
Adverse events and complications
| Categories | CT-guided (n = 47) | MR-guided (n = 54) | P Value | ||
|---|---|---|---|---|---|
| Grades | |||||
| Adverse events | CTCAE | CTCAE | |||
| Fever, maximum 38 °C, no treatment | I | 17(36) | I | 23(43) | 0.546* |
| Fever, > 38 °C, treatment | II | 13(28) | II | 21(39) | 0.293* |
| Nausea or vomiting | II | 7(15) | II | 6(11) | 0.767* |
| Mild pain, requiring nonopioid oral analgesic treatment | II | 24(51) | II | 31(57) | 0.553* |
| Moderate pain, requiring opioid oral analgesic treatment | II | 18(38) | II | 21(39) | 1.000* |
| Mild liver dysfunction, requiring conservative treatment | II | 32(68) | II | 43(80) | 0.254* |
| complications | |||||
| Liver abscess | III | 9(19) | III | 3(6) | 0.022* |
| Asymptomatic perihepatic fluid | IV | 2(4) | IV | 1(2) | 0.596§ |
| Pleural effusion | III | 8(17) | III | 1(2) | 0.011* |
| Subcapsular liver hemorrhage | IV | 3(6) | IV | 1(2) | 0.336§ |
National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE version 4.03)
Data are numbers of events. Data in parentheses are percentages
Note. Data are presented as numbers of events. Data in parentheses are percentages. *Pearson χ2 test was used. §Fisher exact test was used